33 results on '"Origa, Raffaella"'
Search Results
2. Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia
3. Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia
4. Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload
5. Hemoglobinopathies and Cancer: Preliminary Results of an Italian Multicenter Experience
6. Atrial Fibrillation Prevalence and Its Management in Transfusion-Dependent Thalassemias: The Fathal Study
7. A Pilot Multicentric Prospective Study on the Usefulness of Peripheral Blood Immunophenotyping As Erythroid Maturation Response Marker during Luspatercept Treatment in Patients Affected By ß-Thalassemia Major and SF3B1+ Myelodysplastic Syndrome
8. Luspatercept in the Treatment of Beta Thalassemia in Italy: Lights and Shadows in Clinical Practice
9. Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm
10. Current growth patterns in children and adolescents with thalassemia major
11. Hemoglobin Utilization in Asplenic and Non-Splenectomized Transfusion Dependent Thalassemia Patients Supported with Pathogen Reduced Red Blood Cell Concentrates in a Phase 3 Study (SPARC)
12. GDF15 and Erythroferrone Mark Erythropoietic Response to ACE-011 (Sotatercept) in Thalassemia
13. Transfusion Therapy in a Multi-Ethnic Sickle Cell Population Real-World Practice. a Preliminary Data Analysis of Multicentre Survey
14. The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions
15. Low Impact of Genetic Modifiers on the Phenotype of Homozygous Beta Thalassemia in the Last Decennial Cohort of Thalassemia Newborns in Sardinia
16. New Film-Coated Tablet Formulation of Deferasirox Is Well Tolerated in Patients with Thalassemia or MDS: Results of the Randomized, Phase II E.C.L.I.P.S.E. Study
17. Renal Safety after More Than a Decade of Deferasirox Use in Patients with Transfusional Hemosiderosis
18. Safety and Efficacy of Direct-Acting Antiviral Drugs in Patients with Haemoglobinophaties and Chronic Hepatitis C Infection
19. Improved Patient-Reported Outcomes with a Film-Coated Versus Dispersible Tablet Formulation of Deferasirox: Results from the Randomized, Phase II E.C.L.I.P.S.E. Study
20. Gene Therapy for Beta Thalassemia: Preliminary Results from the PHASE I/II Tiget-Bthal Trial of Autologous Hematopoietic Stem Cells Genetically Modified with GLOBE Lentiviral Vector
21. International Comparison Study of Toxic Iron Assays in Patients with Iron Overload Disorders
22. Deferasirox–Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload (HYPERION)
23. A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results
24. Effect of Iron Chelators on Cardiac Iron Assessed by MR T2* in Thalassemia Major
25. Onset of Cardiac Iron Loading in Pediatric Patients.
26. Glutathione S-Transferase Gene Polymorphism and Heart Iron Overload in Thalassemia Major.
27. Lack of Heart Iron Overload in Patients with Thalassemia Intermedia.
28. Seasonal variation of pretransfusion hemoglobin levels in patients with thalassemia major
29. Urinary Hepcidin in Thalassemic Syndromes.
30. Neutropenia in Patients with Thalassemia Major.
31. Lack of Correlation between Serum Ferritin and Liver Iron Concentration in Beta-Zero Thalassemia Intermedia.
32. Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia
33. Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.